Back to medications
Medication monograph

leflunomide

ImidazolinesDisease Modifying Antirheumatic Drugs (DMARDs)Antirheumatic AgentsDisease-modifying Antirheumatic AgentsImmunomodulatory AgentsDisease-modifying Antirheumatic Drugs

Clinical reference

Product monograph

LEFLUNOMIDE tablet, film coated

Brands & formulations

Family members

ARAVA

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

ARAVA

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

APO-LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

APO-LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

TEVA-LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

TEVA-LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

SANDOZ LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

SANDOZ LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

ACCEL-LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

ACCEL-LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

MAR-LEFLUNOMIDE

Marketed
10 MGORALTABLET[ "leflunomide" ]
Product monograph

MAR-LEFLUNOMIDE

Marketed
20 MGORALTABLET[ "leflunomide" ]
Product monograph

Pricing

Price information

Arava Tablet

Sanofi Aventis · 10 mg

30: $614.2790: $1802.84

Arava Tablet

Sanofi Aventis · 20 mg

30: $671.4190: $1945.7

Leflunomide Tablet

Generic · 10 mg

90: $399.99

Leflunomide Tablet

Generic · 20 mg

100: $442.84

Classification

Chemical class
Imidazolines
Clinical class
Disease Modifying Antirheumatic Drugs (DMARDs)
Banks class
Antirheumatic Agents, Disease-modifying Antirheumatic Agents
AHFS family
Immunomodulatory Agents, Disease-modifying Antirheumatic Drugs